Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Enrolling by Invitation

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

NCT07474051

Conditions
AML (Acute Myelogenous Leukemia), B-cell Lymphoma, Chronic Disease, +33 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus Dresden, Germany
  • Universitätsklinikum Marburg Marburg, Germany
  • Klinikum der Universität (LMU) Muenchen Munich, Germany
View Trial Details
Enrolling by Invitation

Watch and Wait or Worry and Wait in Indolent Lymphoma

NCT07173790

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations
  • Samsung Medical Center Seoul, Gangnam-gu, South Korea
  • Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea
  • Seoul National University Hospital Seoul, Jongno-gu, South Korea
  • The Catholic University of Korea Seoul, Seocho-gu, South Korea
View Trial Details
Not Yet Recruiting

Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT07739459

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Chu Lyon-Sud Lyon, Pierre Bénite, France
  • Ch Victor Dupouy Argenteuil, France
  • Ch D'Avignon - Hopital Henri Duffaut Avignon, France
  • Ch de La Cote Basque Bayonne, France
View all 17 locations
View Trial Details
Not Yet Recruiting

Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations

NCT07738887

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • HELORA - Hôpital de La Louvière Site Jolimont La Louvière, Belgium
  • U.Z. LEUVEN - Campus GASTHUISBERG Leuven, Belgium
View all 29 locations
View Trial Details
Not Yet Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions
B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
View Trial Details
Not Yet Recruiting

Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL：Stop Trial 2.0

NCT07682415

Conditions
CLL / SLL, Chronic Disease, Disease Attributes, +14 more
Locations
  • Shenzhen Second People's Hospital Shenzhen, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The Second Xiangya Hospital of Central South University Changsha, Hunan, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
View Trial Details

Related conditions